Navigation Links
Global Warming Expected to Spike Pollen and Spring Allergies - New Drug-Free Topical Gels Boost Hope for Allergy Sufferers
Date:3/11/2009

IRVINGTON, N.Y., March 11 /PRNewswire/ -- Spring has sprung and with it arrives the onset of unrelenting allergy symptoms which for many, will persist throughout the season into summer. For over 40 million Americans in search of allergy relief this season, a solution can't come fast enough. This year, experts predict pollen counts will reach all-time highs due to global warming. Fortunately, there is new hope for sufferers. Chloraseptic(R) Allergen Block and Little Allergies(R) Allergen Block are the first ever, drug-free, preventative solutions available for allergies.

These over-the-counter (OTC) products use an innovative science-based approach to help prevent nasal allergy symptoms by blocking allergens on contact, before they enter the nasal passages. Allergen Block products, sold under the Chloraseptic(R) brand for adults and the Little Remedies(R) brand for children, are topical gels which are applied around the nostrils to block both indoor and outdoor allergens on contact, thereby helping to prevent nasal allergy symptoms. The products are sold for approximately $14.99 at drug stores, mass merchandisers and supermarkets.

The Allergen Block products are drug-free, easy-to-use, and without systemic side effects.(1) These gentle topical gels may be used safely in conjunction with other over-the-counter or prescription medications and can be reapplied as often as needed.

How the Products Work

The Allergen Block products are patented formulations which are designed to work in a novel fashion. The gentle, positively-charged water-based gels help filter negatively-charged allergens in the air on contact. Filtering allergens such as pollen, ragweed, pet dander, and dust mites, helps stop them from entering the nasal passages, where they can cause allergic symptoms such as runny nose and sneezing. Therefore, unlike existing allergy products that treat allergy symptoms once the symptoms have started, Allergen Block products, when used as directed, help prevent the start of mild nasal allergy symptoms by reducing the number of allergen particles entering the nostrils.

How Safe Are the Products?

Chloraseptic(R) and Little Allergies(R) Allergen Block are drug-free, they are safe to use with other medications because they lack the side effects and potential drug interactions which can often accompany the use of systemic medications. The products are safe for use in both children and adults who need a gentle way to combat allergies without the worry of drug side effects.

(1) For best results use before symptoms start. Apply product at opening of nostrils and repeat every 4-6 hours. This product may be used in conjunction with other allergy medications for additional relief.


'/>"/>
SOURCE Chloraseptic(R) Allergen Block
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
4. Briefing on a new Web resource to address global drinking water crisis
5. MDS Pharma Services Wins Award for Management of Global Malaria Trial
6. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
7. Resonant Medical Appoints New Vice President of Global Sales
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
10. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
11. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... More than ... Democratic Republic of Congo (DRC) thanks to an ambitious venture that conjoined the passions ... as the generous support of the Liberty community. These shoes will save lives from ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... highly specialized asset-light logistics provider of complex transport solutions for mission-critical and ... purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: ...
(Date:8/18/2017)... York, NY (PRWEB) , ... August 18, 2017 ... ... launch of this summer’s edition of “Vision & Hearing,” advocating for active, healthy ... campaign focuses on resources available for individuals with hearing impairments and shares the ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, a ... throughout the greater DC region, is inaugurating a “New Leash On Life” charity ... and training them to be companions for veterans in need. , The Semper ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... OCEANSIDE, Calif. , Aug. 15, 2017  AOTI Inc. announced ... Advanced Oxygen Therapy Inc., has recently opened a New York City ... the ever-increasing usage of its unique Topical Wound Oxygen (TWO 2 ... approved by the Accreditation Commission for Health Care (ACHC) under the ... ...
(Date:8/11/2017)... DarioHealth Corp. (NASDAQ: DRIO), a leading global ... solutions, today announced that it will release its second ... a conference call at 9:00am ET. The Company will ... and its strategy and outlook for the remainder of ... Raphael , Chief Executive Officer, and Zvi Ben-David ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
Breaking Medicine Technology: